Arthur J. Gallagher & Co. has announced the appointment of Christopher C. Miskel to its board of directors.
Miskel is president and CEO of Versiti. Prior to that, he served in senior management roles at Baxter International, Baxalta Incorporated, and Shire. He has also served in various roles at Eli Lilly and Company, including management positions in Australia and New Zealand.
“We are very pleased to welcome Chris to our board of directors,” said J. Patrick Gallagher Jr., chairman, president and CEO of Arthur J. Gallagher. “His senior leadership experience in the healthcare industry and his significant sales and marketing experience will add a valuable perspective to our board of directors. Our board and executive management team look forward to working with Chris and benefitting from his judgment and counsel.”
